Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | ataxin 2 | Starlite/ChEMBL | No references |
Homo sapiens | isocitrate dehydrogenase 1 (NADP+), soluble | Starlite/ChEMBL | No references |
Homo sapiens | glucagon-like peptide 1 receptor | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Loa Loa (eye worm) | pigment dispersing factor receptor c | glucagon-like peptide 1 receptor | 463 aa | 388 aa | 25.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Plasmodium vivax | ataxin-2 like protein, putative | 0.003 | 0.0037 | 1 |
Mycobacterium leprae | Probable anthranilate phosphoribosyltransferase TrpD | 0.0876 | 0.2778 | 0.5 |
Brugia malayi | hypothetical protein | 0.003 | 0.0037 | 0.2763 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.006 | 0.0133 | 1 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.003 | 0.0037 | 1 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.006 | 0.0133 | 1 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.003 | 0.0037 | 1 |
Mycobacterium ulcerans | thymidine phosphorylase | 0.3102 | 1 | 1 |
Brugia malayi | hypothetical protein | 0.002 | 0.0002 | 0.0139 |
Loa Loa (eye worm) | hypothetical protein | 0.003 | 0.0037 | 0.2763 |
Loa Loa (eye worm) | hypothetical protein | 0.0041 | 0.0072 | 0.5368 |
Leishmania major | hypothetical protein, conserved | 0.003 | 0.0037 | 1 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.006 | 0.0133 | 1 |
Mycobacterium tuberculosis | Probable anthranilate phosphoribosyltransferase TrpD | 0.0876 | 0.2778 | 0.2778 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.003 | 0.0037 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0041 | 0.0072 | 1 |
Echinococcus multilocularis | thymidine phosphorylase | 0.3102 | 1 | 1 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0041 | 0.0072 | 0.5368 |
Trypanosoma brucei | PAB1-binding protein , putative | 0.003 | 0.0037 | 1 |
Mycobacterium tuberculosis | Probable thymidine phosphorylase DeoA (tdrpase) (pyrimidine phosphorylase) | 0.3102 | 1 | 1 |
Toxoplasma gondii | LsmAD domain-containing protein | 0.003 | 0.0037 | 1 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.003 | 0.0037 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.0133 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 10 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 15.8489 uM | PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 16.3601 uM | PubChem BioAssay. qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 22.3872 uM | PubChem BioAssay. qHTS of TDP-43 Inhibitors. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 28.1838 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b: Cytotox Counterscreen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588855, AID588860] | ChEMBL. | No reference |
Potency (functional) | 35.4813 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860] | ChEMBL. | No reference |
Potency (functional) | 35.4813 uM | PubChem BioAssay. qHTS of alpha-syn Inhibitors. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 56.2341 uM | PubChem BioAssay. qHTS Assay for Inhibitors of the HIV-1 protein Vpr. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 79.4328 uM | PubChem BioAssay. qHTS of PTHR Inhibitors: Primary Screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.